<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1987-03-20" modified="2018-01-31" version="188">
<accession>P04180</accession>
<accession>Q53XQ3</accession>
<name>LCAT_HUMAN</name>
<protein>
<recommendedName>
<fullName>Phosphatidylcholine-sterol acyltransferase</fullName>
<ecNumber evidence="7 8 13 24 27 28 30">2.3.1.43</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Lecithin-cholesterol acyltransferase</fullName>
</alternativeName>
<alternativeName>
<fullName>Phospholipid-cholesterol acyltransferase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">LCAT</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Nucleic Acids Res." volume="14" first="9397" last="9406">
<title>Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression.</title>
<authorList>
<person name="McLean J."/>
<person name="Wion K."/>
<person name="Drayna D."/>
<person name="Fielding C."/>
<person name="Lawn R."/>
</authorList>
<dbReference type="PubMed" id="3797244"/>
<dbReference type="DOI" id="10.1093/nar/14.23.9397"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="2335" last="2339">
<title>Cloning and expression of human lecithin-cholesterol acyltransferase cDNA.</title>
<authorList>
<person name="McLean J."/>
<person name="Fielding C."/>
<person name="Drayna D."/>
<person name="Dieplinger H."/>
<person name="Baer B."/>
<person name="Kohr W."/>
<person name="Henzel W."/>
<person name="Lawn R."/>
</authorList>
<dbReference type="PubMed" id="3458198"/>
<dbReference type="DOI" id="10.1073/pnas.83.8.2335"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PROTEIN SEQUENCE OF 25-39; 172-182; 269-280 AND 387-406</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="submission" date="2003-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Nickerson D.A."/>
<person name="Smith J.D."/>
<person name="Fullerton S.M."/>
<person name="Clark A.G."/>
<person name="Stengard J.H."/>
<person name="Salomaa V."/>
<person name="Boerwinkle E."/>
<person name="Sing C.F."/>
<person name="Weiss K.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-08" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1987" name="Biochim. Biophys. Acta" volume="910" first="142" last="148">
<title>The isolation and characterisation of cDNA and genomic clones for human lecithin: cholesterol acyltransferase.</title>
<authorList>
<person name="Tata F."/>
<person name="Chaves M.E."/>
<person name="Markham A.F."/>
<person name="Scrace G.D."/>
<person name="Waterfield M.D."/>
<person name="McIntyre N."/>
<person name="Williamson R."/>
<person name="Humphries S.E."/>
</authorList>
<dbReference type="PubMed" id="2823898"/>
<dbReference type="DOI" id="10.1016/0167-4781(87)90066-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 17-440</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1987" name="Biochem. Biophys. Res. Commun." volume="148" first="161" last="169">
<title>The isolation and characterisation of a cDNA clone for human lecithin:cholesterol acyl transferase and its use to analyse the genes in patients with LCAT deficiency and fish eye disease.</title>
<authorList>
<person name="Rogne S."/>
<person name="Skretting G."/>
<person name="Larsen F."/>
<person name="Myklebost O."/>
<person name="Mevag B."/>
<person name="Carlson L.A."/>
<person name="Holmquist L."/>
<person name="Gjone E."/>
<person name="Prydz H."/>
</authorList>
<dbReference type="PubMed" id="2823801"/>
<dbReference type="DOI" id="10.1016/0006-291X(87)91090-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 13-440</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1987" name="J. Biol. Chem." volume="262" first="3086" last="3091">
<title>Lecithin:cholesterol acyltransferase. Functional regions and a structural model of the enzyme.</title>
<authorList>
<person name="Yang C."/>
<person name="Manoogian D."/>
<person name="Pao Q."/>
<person name="Lee F."/>
<person name="Knapp R.D."/>
<person name="Gotto A.M. Jr."/>
<person name="Pownall H.J."/>
</authorList>
<dbReference type="PubMed" id="2880847"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="Protein Sci." volume="4" first="791" last="803">
<title>Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion.</title>
<authorList>
<person name="Schindler P.A."/>
<person name="Settineri C.A."/>
<person name="Collet X."/>
<person name="Fielding C.J."/>
<person name="Burlingame A.L."/>
</authorList>
<dbReference type="PubMed" id="7613477"/>
<dbReference type="DOI" id="10.1002/pro.5560040419"/>
</citation>
<scope>GLYCOSYLATION AT ASN-44; ASN-108; ASN-296; ASN-408; THR-431 AND SER-433</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1996" name="J. Lipid Res." volume="37" first="113" last="122">
<title>Comparative studies on the substrate specificity of lecithin:cholesterol acyltransferase towards the molecular species of phosphatidylcholine in the plasma of 14 vertebrates.</title>
<authorList>
<person name="Subbaiah P.V."/>
<person name="Liu M."/>
</authorList>
<dbReference type="PubMed" id="8820107"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="258" first="73" last="76">
<title>Secretion of lecithin:cholesterol acyltransferase by brain neuroglial cell lines.</title>
<authorList>
<person name="Collet X."/>
<person name="Francone O."/>
<person name="Besnard F."/>
<person name="Fielding C.J."/>
</authorList>
<dbReference type="PubMed" id="10222237"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0601"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="258" first="548" last="551">
<title>Binding affinity and reactivity of lecithin cholesterol acyltransferase with native lipoproteins.</title>
<authorList>
<person name="Kosek A.B."/>
<person name="Durbin D."/>
<person name="Jonas A."/>
</authorList>
<dbReference type="PubMed" id="10329423"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0690"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="9019" last="9025">
<title>Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase.</title>
<authorList>
<person name="Clay M.A."/>
<person name="Pyle D.H."/>
<person name="Rye K.A."/>
<person name="Barter P.J."/>
</authorList>
<dbReference type="PubMed" id="10722751"/>
<dbReference type="DOI" id="10.1074/jbc.275.12.9019"/>
</citation>
<scope>FUNCTION IN HIGH-DENSITY LIPOPROTEIN PARTICLE REMODELING</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Biochemistry" volume="42" first="13941" last="13949">
<title>Negative charge at amino acid 149 is the molecular determinant for substrate specificity of lecithin: cholesterol acyltransferase for phosphatidylcholine containing 20-carbon sn-2 fatty acyl chains.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Wang J."/>
<person name="Gebre A.K."/>
<person name="Chisholm J.W."/>
<person name="Parks J.S."/>
</authorList>
<dbReference type="PubMed" id="14636062"/>
<dbReference type="DOI" id="10.1021/bi035460u"/>
</citation>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>MUTAGENESIS OF GLU-173</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-44 AND ASN-296</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Metabolism" volume="56" first="1542" last="1549">
<title>Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.</title>
<authorList>
<person name="Bajnok L."/>
<person name="Seres I."/>
<person name="Varga Z."/>
<person name="Jeges S."/>
<person name="Peti A."/>
<person name="Karanyi Z."/>
<person name="Juhasz A."/>
<person name="Csongradi E."/>
<person name="Mezosi E."/>
<person name="Nagy E.V."/>
<person name="Paragh G."/>
</authorList>
<dbReference type="PubMed" id="17950106"/>
<dbReference type="DOI" id="10.1016/j.metabol.2007.06.022"/>
</citation>
<scope>ASSOCIATION WITH OBESITY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Lipid Res." volume="50" first="885" last="893">
<title>LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins.</title>
<authorList>
<person name="Hirsch-Reinshagen V."/>
<person name="Donkin J."/>
<person name="Stukas S."/>
<person name="Chan J."/>
<person name="Wilkinson A."/>
<person name="Fan J."/>
<person name="Parks J.S."/>
<person name="Kuivenhoven J.A."/>
<person name="Lutjohann D."/>
<person name="Pritchard H."/>
<person name="Wellington C.L."/>
</authorList>
<dbReference type="PubMed" id="19065001"/>
<dbReference type="DOI" id="10.1194/jlr.M800584-JLR200"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2015" name="J. Lipid Res." volume="56" first="1711" last="1719">
<title>The high resolution crystal structure of human LCAT.</title>
<authorList>
<person name="Piper D.E."/>
<person name="Romanow W.G."/>
<person name="Gunawardane R.N."/>
<person name="Fordstrom P."/>
<person name="Masterman S."/>
<person name="Pan O."/>
<person name="Thibault S.T."/>
<person name="Zhang R."/>
<person name="Meininger D."/>
<person name="Schwarz M."/>
<person name="Wang Z."/>
<person name="King C."/>
<person name="Zhou M."/>
<person name="Walker N.P."/>
</authorList>
<dbReference type="PubMed" id="26195816"/>
<dbReference type="DOI" id="10.1194/jlr.M059873"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 25-440</scope>
<scope>DISULFIDE BONDS</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>GLYCOSYLATION AT ASN-108; ASN-296 AND ASN-408</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="6250" last="6250">
<title>Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase.</title>
<authorList>
<person name="Glukhova A."/>
<person name="Hinkovska-Galcheva V."/>
<person name="Kelly R."/>
<person name="Abe A."/>
<person name="Shayman J.A."/>
<person name="Tesmer J.J."/>
</authorList>
<dbReference type="PubMed" id="25727495"/>
<dbReference type="DOI" id="10.1038/ncomms7250"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (8.69 ANGSTROMS) OF 45-421</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-108; ASN-296 AND ASN-408</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1992" name="Biochem. Biophys. Res. Commun." volume="182" first="583" last="587">
<title>An amino acid exchange in exon I of the human lecithin: cholesterol acyltransferase (LCAT) gene is associated with fish eye disease.</title>
<authorList>
<person name="Skretting G."/>
<person name="Prydz H."/>
</authorList>
<dbReference type="PubMed" id="1571050"/>
<dbReference type="DOI" id="10.1016/0006-291X(92)91772-I"/>
</citation>
<scope>VARIANT FED LEU-34</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1992" name="J. Clin. Invest." volume="89" first="499" last="506">
<title>Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123-->Ile) and lecithin-cholesterol acyltransferase (Thr347-->Met).</title>
<authorList>
<person name="Klein H.-G."/>
<person name="Lohse P."/>
<person name="Pritchard P.H."/>
<person name="Bojanovski D."/>
<person name="Schmidt H."/>
<person name="Brewer H.B. Jr."/>
</authorList>
<dbReference type="PubMed" id="1737840"/>
<dbReference type="DOI" id="10.1172/JCI115612"/>
</citation>
<scope>VARIANTS FED ILE-147 AND MET-371</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1990" name="Hum. Genet." volume="85" first="195" last="199">
<title>Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele.</title>
<authorList>
<person name="Taramelli R."/>
<person name="Pontoglio M."/>
<person name="Candiani G."/>
<person name="Ottolenghi S."/>
<person name="Dieplinger H."/>
<person name="Catapano A."/>
<person name="Albers J."/>
<person name="Vergani C."/>
<person name="McLean J."/>
</authorList>
<dbReference type="PubMed" id="2370048"/>
<dbReference type="DOI" id="10.1007/BF00193195"/>
</citation>
<scope>VARIANT LCATD TRP-171</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1991" name="Lancet" volume="338" first="778" last="781">
<title>Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency.</title>
<authorList>
<person name="Gotoda T."/>
<person name="Yamada N."/>
<person name="Murase T."/>
<person name="Sakuma M."/>
<person name="Murayama N."/>
<person name="Shimano H."/>
<person name="Kozaki K."/>
<person name="Albers J.J."/>
<person name="Yazaki Y."/>
<person name="Akanuma Y."/>
</authorList>
<dbReference type="PubMed" id="1681161"/>
<dbReference type="DOI" id="10.1016/0140-6736(91)90665-C"/>
</citation>
<scope>VARIANTS LCATD LYS-252 AND ILE-317</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1992" name="FEBS Lett." volume="309" first="307" last="310">
<title>The genetic defect of the original Norwegian lecithin:cholesterol acyltransferase deficiency families.</title>
<authorList>
<person name="Skretting G."/>
<person name="Blomhoff J.P."/>
<person name="Solheim J."/>
<person name="Prydz H."/>
</authorList>
<dbReference type="PubMed" id="1516702"/>
<dbReference type="DOI" id="10.1016/0014-5793(92)80795-I"/>
</citation>
<scope>VARIANT FED LYS-276</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1991" name="Biochem. Biophys. Res. Commun." volume="178" first="460" last="466">
<title>Lecithin-cholesterol acyltransferase (LCAT) deficiency with a missense mutation in exon 6 of the LCAT gene.</title>
<authorList>
<person name="Maeda E."/>
<person name="Naka Y."/>
<person name="Matozaki T."/>
<person name="Sakuma M."/>
<person name="Akanuma Y."/>
<person name="Yoshino G."/>
<person name="Kasuga M."/>
</authorList>
<dbReference type="PubMed" id="1859405"/>
<dbReference type="DOI" id="10.1016/0006-291X(91)90129-U"/>
</citation>
<scope>VARIANT LCATD ILE-317</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1993" name="J. Clin. Invest." volume="91" first="677" last="683">
<title>Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease.</title>
<authorList>
<person name="Funke H."/>
<person name="von Eckardstein A."/>
<person name="Pritchard P.H."/>
<person name="Hornby A.E."/>
<person name="Wiebusch H."/>
<person name="Motti C."/>
<person name="Hayden M.R."/>
<person name="Dachet C."/>
<person name="Jacotot B."/>
<person name="Gerdes U."/>
<person name="Faergeman O."/>
<person name="Albers J.J."/>
<person name="Colleoni N."/>
<person name="Catapano A."/>
<person name="Frohlich J."/>
<person name="Assmann G."/>
</authorList>
<dbReference type="PubMed" id="8432868"/>
<dbReference type="DOI" id="10.1172/JCI116248"/>
</citation>
<scope>VARIANTS LCATD THR-117; TRP-159; PRO-233 AND MET-345</scope>
<scope>VARIANT CYS-182</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1993" name="Biochim. Biophys. Acta" volume="1181" first="321" last="323">
<title>Lecithin:cholesterol acyltransferase deficiency: identification of a causative gene mutation and a co-inherited protein polymorphism.</title>
<authorList>
<person name="Hill J.S."/>
<person name="O K."/>
<person name="Wang X."/>
<person name="Pritchard P.H."/>
</authorList>
<dbReference type="PubMed" id="8318557"/>
<dbReference type="DOI" id="10.1016/0925-4439(93)90039-4"/>
</citation>
<scope>VARIANT LCATD THR-117</scope>
<scope>VARIANT CYS-182</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1995" name="Hum. Genet." volume="96" first="105" last="109">
<title>A single G to A nucleotide transition in exon IV of the lecithin: cholesterol acyltransferase (LCAT) gene results in an Arg140 to His substitution and causes LCAT-deficiency.</title>
<authorList>
<person name="Steyrer E."/>
<person name="Haubenwallner S."/>
<person name="Hoerl G."/>
<person name="Giessauf W."/>
<person name="Kostner G.M."/>
<person name="Zechner R."/>
</authorList>
<dbReference type="PubMed" id="7607641"/>
<dbReference type="DOI" id="10.1007/BF00214196"/>
</citation>
<scope>VARIANT LCATD HIS-164</scope>
<scope>CHARACTERIZATION OF VARIANT LCATD HIS-164</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="143" last="145">
<title>Deficiency of lecithin:cholesterol acyltransferase due to compound heterozygosity of two novel mutations (Gly33Arg and 30 bp ins) in the LCAT gene.</title>
<authorList>
<person name="Wiebusch H."/>
<person name="Cullen P."/>
<person name="Owen J.S."/>
<person name="Collins D."/>
<person name="Sharp P.S."/>
<person name="Funke H."/>
<person name="Assmann G."/>
</authorList>
<dbReference type="PubMed" id="7711728"/>
<dbReference type="DOI" id="10.1093/hmg/4.1.143"/>
</citation>
<scope>VARIANTS LCATD ARG-57 AND LEU-LEU-PRO-PRO-ALA-ALA-PRO-PHE-TRP-LEU-17 INS</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1996" name="Arterioscler. Thromb. Vasc. Biol." volume="16" first="294" last="303">
<title>Two novel molecular defects in the LCAT gene are associated with fish eye disease.</title>
<authorList>
<person name="Kuivenhoven J.A."/>
<person name="Stalenhoef A.F."/>
<person name="Hill J.S."/>
<person name="Demacker P.N."/>
<person name="Errami A."/>
<person name="Kastelein J.J."/>
<person name="Pritchard P.H."/>
</authorList>
<dbReference type="PubMed" id="8620346"/>
<dbReference type="DOI" id="10.1161/01.ATV.16.2.294"/>
</citation>
<scope>VARIANTS FED GLN-34 AND GLN-159</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="79" last="82">
<title>Complete deficiency of plasma lecithin-cholesterol acyltransferase (LCAT) activity due to a novel homozygous mutation (Gly-30-Ser) in the LCAT gene.</title>
<authorList>
<person name="Owen J.S."/>
<person name="Wiebusch H."/>
<person name="Cullen P."/>
<person name="Watts G.F."/>
<person name="Lima V.L.M."/>
<person name="Funke H."/>
<person name="Assmann G."/>
</authorList>
<dbReference type="PubMed" id="8807342"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)8:1&lt;79::AID-HUMU13>3.0.CO;2-O"/>
</citation>
<scope>VARIANT LCATD SER-54</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1996" name="Int. J. Clin. Lab. Res." volume="26" first="250" last="254">
<title>A novel missense mutation (Asn5-->Ile) in lecithin: cholesterol acyltransferase (LCAT) gene in a Japanese patient with LCAT deficiency.</title>
<authorList>
<person name="Okubo M."/>
<person name="Aoyama Y."/>
<person name="Shio H."/>
<person name="Albers J.J."/>
<person name="Murase T."/>
</authorList>
<dbReference type="PubMed" id="9007616"/>
<dbReference type="DOI" id="10.1007/BF02602958"/>
</citation>
<scope>VARIANT LCATD ILE-29</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1997" name="Arterioscler. Thromb. Vasc. Biol." volume="17" first="1382" last="1391">
<title>Molecular basis of fish-eye disease in a patient from Spain. Characterization of a novel mutation in the LCAT gene and lipid analysis of the cornea.</title>
<authorList>
<person name="Blanco-Vaca F."/>
<person name="Qu S.J."/>
<person name="Fiol C."/>
<person name="Fan H.Z."/>
<person name="Pao Q."/>
<person name="Marzal-Casacuberta A."/>
<person name="Albers J.J."/>
<person name="Hurtado I."/>
<person name="Gracia V."/>
<person name="Pinto X."/>
<person name="Marti T."/>
<person name="Pownall H.J."/>
</authorList>
<dbReference type="PubMed" id="9261271"/>
<dbReference type="DOI" id="10.1161/01.ATV.17.7.1382"/>
</citation>
<scope>VARIANT FED CYS-123</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1998" name="J. Lipid Res." volume="39" first="1870" last="1876">
<title>Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband.</title>
<authorList>
<person name="Argyropoulos G."/>
<person name="Jenkins A."/>
<person name="Klein R.L."/>
<person name="Lyons T."/>
<person name="Wagenhorst B."/>
<person name="St Armand J."/>
<person name="Marcovina S.M."/>
<person name="Albers J.J."/>
<person name="Pritchard P.H."/>
<person name="Garvey W.T."/>
</authorList>
<dbReference type="PubMed" id="9741700"/>
</citation>
<scope>VARIANTS LCATD MET-37 AND SER-331</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2001" name="Nephron" volume="88" first="268" last="272">
<title>Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations.</title>
<authorList>
<person name="Sessa A."/>
<person name="Battini G."/>
<person name="Meroni M."/>
<person name="Daidone G."/>
<person name="Carnera I."/>
<person name="Brambilla P.L."/>
<person name="Vigano G."/>
<person name="Giordano F."/>
<person name="Pallotti F."/>
<person name="Torri Tarelli L."/>
<person name="Calabresi L."/>
<person name="Rolleri M."/>
<person name="Bertolini S."/>
</authorList>
<dbReference type="PubMed" id="11423760"/>
<dbReference type="DOI" id="10.1159/000046001"/>
</citation>
<scope>VARIANT LCATD ALA-298</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2003" name="Atherosclerosis" volume="170" first="105" last="113">
<title>A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.</title>
<authorList>
<person name="Nanjee M.N."/>
<person name="Stocks J."/>
<person name="Cooke C.J."/>
<person name="Molhuizen H.O."/>
<person name="Marcovina S."/>
<person name="Crook D."/>
<person name="Kastelein J.P."/>
<person name="Miller N.E."/>
</authorList>
<dbReference type="PubMed" id="12957688"/>
<dbReference type="DOI" id="10.1016/S0021-9150(03)00241-7"/>
</citation>
<scope>VARIANTS LCATD MET-345 AND VAL-406</scope>
<scope>VARIANT THR-232</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="2733" last="2743">
<title>Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.</title>
<authorList>
<person name="Morabia A."/>
<person name="Cayanis E."/>
<person name="Costanza M.C."/>
<person name="Ross B.M."/>
<person name="Flaherty M.S."/>
<person name="Alvin G.B."/>
<person name="Das K."/>
<person name="Gilliam T.C."/>
</authorList>
<dbReference type="PubMed" id="12966036"/>
<dbReference type="DOI" id="10.1093/hmg/ddg314"/>
</citation>
<scope>VARIANT THR-232</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="Arterioscler. Thromb. Vasc. Biol." volume="25" first="1972" last="1978">
<title>The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.</title>
<authorList>
<person name="Calabresi L."/>
<person name="Pisciotta L."/>
<person name="Costantin A."/>
<person name="Frigerio I."/>
<person name="Eberini I."/>
<person name="Alessandrini P."/>
<person name="Arca M."/>
<person name="Bon G.B."/>
<person name="Boscutti G."/>
<person name="Busnach G."/>
<person name="Frasca G."/>
<person name="Gesualdo L."/>
<person name="Gigante M."/>
<person name="Lupattelli G."/>
<person name="Montali A."/>
<person name="Pizzolitto S."/>
<person name="Rabbone I."/>
<person name="Rolleri M."/>
<person name="Ruotolo G."/>
<person name="Sampietro T."/>
<person name="Sessa A."/>
<person name="Vaudo G."/>
<person name="Cantafora A."/>
<person name="Veglia F."/>
<person name="Calandra S."/>
<person name="Bertolini S."/>
<person name="Franceschini G."/>
</authorList>
<dbReference type="PubMed" id="15994445"/>
<dbReference type="DOI" id="10.1161/01.ATV.0000175751.30616.13"/>
</citation>
<scope>VARIANTS FED GLU-70 AND ALA-298</scope>
<scope>VARIANTS LCATD CYS-164; TRP-171; ASN-205; ASN-242; HIS-268; ILE-298 AND MET-333</scope>
<scope>VARIANTS PRO-115; THR-165 AND ARG-396</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2006" name="Atherosclerosis" volume="185" first="413" last="420">
<title>Familial lecithin-cholesterol acyltransferase deficiency: biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family.</title>
<authorList>
<person name="Idzior-Walus B."/>
<person name="Sieradzki J."/>
<person name="Kostner G."/>
<person name="Malecki M.T."/>
<person name="Klupa T."/>
<person name="Wesolowska T."/>
<person name="Rostworowski W."/>
<person name="Hartwich J."/>
<person name="Walus M."/>
<person name="Kiec A.D."/>
<person name="Naruszewicz M."/>
</authorList>
<dbReference type="PubMed" id="16051254"/>
<dbReference type="DOI" id="10.1016/j.atherosclerosis.2005.06.022"/>
</citation>
<scope>VARIANT LCATD MET-333</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2006" name="Atherosclerosis" volume="187" first="101" last="109">
<title>Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.</title>
<authorList>
<person name="Hoerl G."/>
<person name="Kroisel P.M."/>
<person name="Wagner E."/>
<person name="Tiran B."/>
<person name="Petek E."/>
<person name="Steyrer E."/>
</authorList>
<dbReference type="PubMed" id="16216249"/>
<dbReference type="DOI" id="10.1016/j.atherosclerosis.2005.08.038"/>
</citation>
<scope>VARIANT ARG-95</scope>
<scope>VARIANT LCATD HIS-164</scope>
<scope>CHARACTERIZATION OF VARIANT ARG-95</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2006" name="J. Nephrol." volume="19" first="375" last="381">
<title>LCAT deficiency: molecular and phenotypic characterization of an Italian family.</title>
<authorList>
<person name="Gigante M."/>
<person name="Ranieri E."/>
<person name="Cerullo G."/>
<person name="Calabresi L."/>
<person name="Iolascon A."/>
<person name="Assmann G."/>
<person name="Morrone L."/>
<person name="Pisciotta L."/>
<person name="Schena F.P."/>
<person name="Gesualdo L."/>
</authorList>
<dbReference type="PubMed" id="16874701"/>
</citation>
<scope>VARIANTS THR-232 AND ARG-396</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="Hum. Mutat." volume="32" first="1290" last="1298">
<title>High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations.</title>
<authorList>
<person name="Holleboom A.G."/>
<person name="Kuivenhoven J.A."/>
<person name="Peelman F."/>
<person name="Schimmel A.W."/>
<person name="Peter J."/>
<person name="Defesche J.C."/>
<person name="Kastelein J.J."/>
<person name="Hovingh G.K."/>
<person name="Stroes E.S."/>
<person name="Motazacker M.M."/>
</authorList>
<dbReference type="PubMed" id="21901787"/>
<dbReference type="DOI" id="10.1002/humu.21578"/>
</citation>
<scope>VARIANTS 134-GLU-TYR-135 DELINS ASP-ASN; PHE-246; CYS-268 AND CYS-322</scope>
<scope>VARIANTS FED SER-99; PHE-338 AND CYS-347</scope>
<scope>CHARACTERIZATION OF VARIANTS 134-GLU-TYR-135 DELINS ASP-ASN; PHE-246; CYS-268 AND CYS-322</scope>
<scope>CHARACTERIZATION OF VARIANTS FED SER-99; PHE-338 CYS-347 AND CYS-347</scope>
</reference>
<comment type="function">
<text evidence="8 9 13 24 28 39">Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs) (PubMed:10329423, PubMed:19065001, PubMed:26195816). The cholesterol ester is then transported back to the liver. Has a preference for plasma 16:0-18:2 or 18:O-18:2 phosphatidylcholines (PubMed:8820107). Also produced in the brain by primary astrocytes, and esterifies free cholesterol on nascent APOE-containing lipoproteins secreted from glia and influences cerebral spinal fluid (CSF) APOE- and APOA1 levels. Together with APOE and the cholesterol transporter ABCA1, plays a key role in the maturation of glial-derived, nascent lipoproteins. Required for remodeling high-density lipoprotein particles into their spherical forms (PubMed:10722751).</text>
</comment>
<comment type="catalytic activity">
<text evidence="6 7 8 13 24 27 28 30 39">Phosphatidylcholine + a sterol = 1-acylglycerophosphocholine + a sterol ester.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="24">APOA1 is the most potent activator in plasma. Also activated by APOE, APOC1 and APOA4.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="8">0.97 mM for LDL</KM>
<KM evidence="8">0.4 mM for HDL(2)</KM>
<KM evidence="8">0.10 mM for HDL(3)</KM>
<Vmax evidence="8">8.3 mmol/min/mg enzyme with LDL as substrate</Vmax>
<Vmax evidence="8">0.58 mmol/min/mg enzyme with HDL(2) as substrate</Vmax>
<Vmax evidence="8">2.0 mmol/min/mg enzyme with HDL(3) as substrate</Vmax>
<text>Affinity for LDL is 2.3 to 4-fold lower than for HDL. Relative reactivities are 16% for HDL(3), 1.3% for HDL(2) and 6.5% for LDL.</text>
</kinetics>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9104464"/>
<interactant intactId="EBI-701692">
<id>P02647</id>
<label>APOA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7 24 30 39">Secreted</location>
</subcellularLocation>
<text evidence="7 30 39">Secreted into blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Produced in astrocytes and secreted into cerebral spinal fluid (CSF).</text>
</comment>
<comment type="tissue specificity">
<text evidence="7 30 31 39">Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes.</text>
</comment>
<comment type="PTM">
<text evidence="19 33">O- and N-glycosylated. O-glycosylation on Thr-431 and Ser-433 consists of sialylated galactose beta 1-->3N-acetylgalactosamine structures. N-glycosylated sites contain sialylated triantennary and/or biantennary complex structures.</text>
</comment>
<comment type="disease" evidence="10 11 16 17 18 20 23 26 32 34 35 36 38 40 42">
<disease id="DI-00642">
<name>Lecithin-cholesterol acyltransferase deficiency</name>
<acronym>LCATD</acronym>
<description>A disorder of lipoprotein metabolism characterized by inadequate esterification of plasmatic cholesterol. Two clinical forms are recognized: complete LCAT deficiency and fish-eye disease. LCATD is generally referred to the complete form which is associated with absence of both alpha and beta LCAT activities resulting in esterification anomalies involving both HDL (alpha-LCAT activity) and LDL (beta-LCAT activity). It causes a typical triad of diffuse corneal opacities, target cell hemolytic anemia, and proteinuria with renal failure.</description>
<dbReference type="MIM" id="245900"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="14 15 16 22 25 37 41">
<disease id="DI-00500">
<name>Fish-eye disease</name>
<acronym>FED</acronym>
<description>A disorder of lipoprotein metabolism due to partial lecithin-cholesterol acyltransferase deficiency that affects only alpha-LCAT activity. FED is characterized by low plasma HDL and corneal opacities due to accumulation of cholesterol deposits in the cornea ('fish-eye').</description>
<dbReference type="MIM" id="136120"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Levels of LCAT activity correlates inversely with leptin levels as well as with obesity for a wide range of BMI values.</text>
</comment>
<comment type="similarity">
<text evidence="43">Belongs to the AB hydrolase superfamily. Lipase family.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Lecithin-cholesterol_acyltransferase"/>
<text>Lecithin-cholesterol acyltransferase entry</text>
</comment>
<dbReference type="EC" id="2.3.1.43" evidence="7 8 13 24 27 28 30"/>
<dbReference type="EMBL" id="X04981">
<property type="protein sequence ID" value="CAA28651.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M12625">
<property type="protein sequence ID" value="AAA59498.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY422210">
<property type="protein sequence ID" value="AAR03499.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT009748">
<property type="protein sequence ID" value="AAP88750.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC040162">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471092">
<property type="protein sequence ID" value="EAW83190.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014781">
<property type="protein sequence ID" value="AAH14781.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M26268">
<property type="protein sequence ID" value="AAA59499.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X06537">
<property type="protein sequence ID" value="CAB56610.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M17959">
<property type="protein sequence ID" value="AAA59500.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10854.1"/>
<dbReference type="PIR" id="A00571">
<property type="entry name" value="XXHUN"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000220.1">
<property type="nucleotide sequence ID" value="NM_000229.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.387239"/>
<dbReference type="PDB" id="4X96">
<property type="method" value="X-ray"/>
<property type="resolution" value="8.69"/>
<property type="chains" value="A/B/C/D=45-421"/>
</dbReference>
<dbReference type="PDB" id="4XWG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=25-440"/>
</dbReference>
<dbReference type="PDB" id="4XX1">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/B/J=25-440"/>
</dbReference>
<dbReference type="PDB" id="5BV7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=25-440"/>
</dbReference>
<dbReference type="PDB" id="5TXF">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/C/D=25-440"/>
</dbReference>
<dbReference type="PDBsum" id="4X96"/>
<dbReference type="PDBsum" id="4XWG"/>
<dbReference type="PDBsum" id="4XX1"/>
<dbReference type="PDBsum" id="5BV7"/>
<dbReference type="PDBsum" id="5TXF"/>
<dbReference type="ProteinModelPortal" id="P04180"/>
<dbReference type="SMR" id="P04180"/>
<dbReference type="BioGrid" id="110123">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="DIP" id="DIP-29620N"/>
<dbReference type="IntAct" id="P04180">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000264005"/>
<dbReference type="BindingDB" id="P04180"/>
<dbReference type="ChEMBL" id="CHEMBL5942"/>
<dbReference type="SwissLipids" id="SLP:000000660"/>
<dbReference type="ESTHER" id="human-LCAT">
<property type="family name" value="PC-sterol_acyltransferase"/>
</dbReference>
<dbReference type="iPTMnet" id="P04180"/>
<dbReference type="PhosphoSitePlus" id="P04180"/>
<dbReference type="UniCarbKB" id="P04180"/>
<dbReference type="BioMuta" id="LCAT"/>
<dbReference type="DMDM" id="125993"/>
<dbReference type="MaxQB" id="P04180"/>
<dbReference type="PaxDb" id="P04180"/>
<dbReference type="PeptideAtlas" id="P04180"/>
<dbReference type="PRIDE" id="P04180"/>
<dbReference type="DNASU" id="3931"/>
<dbReference type="Ensembl" id="ENST00000264005">
<property type="protein sequence ID" value="ENSP00000264005"/>
<property type="gene ID" value="ENSG00000213398"/>
</dbReference>
<dbReference type="GeneID" id="3931"/>
<dbReference type="KEGG" id="hsa:3931"/>
<dbReference type="UCSC" id="uc002euy.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3931"/>
<dbReference type="DisGeNET" id="3931"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000213398.7"/>
<dbReference type="GeneCards" id="LCAT"/>
<dbReference type="H-InvDB" id="HIX0134431"/>
<dbReference type="HGNC" id="HGNC:6522">
<property type="gene designation" value="LCAT"/>
</dbReference>
<dbReference type="HPA" id="HPA044767"/>
<dbReference type="MalaCards" id="LCAT"/>
<dbReference type="MIM" id="136120">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="245900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606967">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04180"/>
<dbReference type="OpenTargets" id="ENSG00000213398"/>
<dbReference type="Orphanet" id="79293">
<property type="disease" value="Familial LCAT deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="79292">
<property type="disease" value="Fish-eye disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA226"/>
<dbReference type="eggNOG" id="KOG2369">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410Y9CF">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000004902"/>
<dbReference type="HOGENOM" id="HOG000238654"/>
<dbReference type="HOVERGEN" id="HBG017055"/>
<dbReference type="InParanoid" id="P04180"/>
<dbReference type="KO" id="K00650"/>
<dbReference type="OMA" id="TYGKPVF"/>
<dbReference type="OrthoDB" id="EOG091G07S3"/>
<dbReference type="PhylomeDB" id="P04180"/>
<dbReference type="TreeFam" id="TF313258"/>
<dbReference type="BRENDA" id="2.3.1.43">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8964058">
<property type="pathway name" value="HDL remodeling"/>
</dbReference>
<dbReference type="SABIO-RK" id="P04180"/>
<dbReference type="SIGNOR" id="P04180"/>
<dbReference type="ChiTaRS" id="LCAT">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Lecithin%E2%80%94cholesterol_acyltransferase"/>
<dbReference type="GenomeRNAi" id="3931"/>
<dbReference type="PRO" id="PR:P04180"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000213398"/>
<dbReference type="CleanEx" id="HS_LCAT"/>
<dbReference type="ExpressionAtlas" id="P04180">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04180">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034364">
<property type="term" value="C:high-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034186">
<property type="term" value="F:apolipoprotein A-I binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004607">
<property type="term" value="F:phosphatidylcholine-sterol O-acyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034435">
<property type="term" value="P:cholesterol esterification"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042632">
<property type="term" value="P:cholesterol homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008203">
<property type="term" value="P:cholesterol metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030301">
<property type="term" value="P:cholesterol transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034375">
<property type="term" value="P:high-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042158">
<property type="term" value="P:lipoprotein biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006656">
<property type="term" value="P:phosphatidylcholine biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046470">
<property type="term" value="P:phosphatidylcholine metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006644">
<property type="term" value="P:phospholipid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090107">
<property type="term" value="P:regulation of high-density lipoprotein particle assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043691">
<property type="term" value="P:reverse cholesterol transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034372">
<property type="term" value="P:very-low-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.1820">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR029058">
<property type="entry name" value="AB_hydrolase"/>
</dbReference>
<dbReference type="InterPro" id="IPR003386">
<property type="entry name" value="LACT/PDAT_acylTrfase"/>
</dbReference>
<dbReference type="Pfam" id="PF02450">
<property type="entry name" value="LCAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53474">
<property type="entry name" value="SSF53474"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00120">
<property type="entry name" value="LIPASE_SER"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0153">Cholesterol metabolism</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-1212">Corneal dystrophy</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0753">Steroid metabolism</keyword>
<keyword id="KW-1207">Sterol metabolism</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="signal peptide" evidence="30">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Phosphatidylcholine-sterol acyltransferase" id="PRO_0000017802">
<location>
<begin position="25"/>
<end position="440"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="426"/>
<end position="439"/>
</location>
</feature>
<feature type="active site" description="Nucleophile" evidence="45">
<location>
<position position="205"/>
</location>
</feature>
<feature type="active site" description="Charge relay system" evidence="45">
<location>
<position position="369"/>
</location>
</feature>
<feature type="active site" description="Charge relay system" evidence="45">
<location>
<position position="401"/>
</location>
</feature>
<feature type="site" description="Determinant for substrate specificity" evidence="44">
<location>
<position position="173"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="19 33">
<location>
<position position="44"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="1 28 33">
<location>
<position position="108"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="1 19 28 33">
<location>
<position position="296"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="1 28 33">
<location>
<position position="408"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="33">
<location>
<position position="431"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="33">
<location>
<position position="433"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 28 29">
<location>
<begin position="74"/>
<end position="98"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 28 29">
<location>
<begin position="337"/>
<end position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_004251">
<original>L</original>
<variation>LLLPPAAPFWL</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_039020" evidence="40">
<original>N</original>
<variation>I</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; dbSNP:rs121908051." id="VAR_004252" evidence="15">
<original>P</original>
<variation>L</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In FED." id="VAR_039021" evidence="37">
<original>P</original>
<variation>Q</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; dbSNP:rs971887742." id="VAR_039022" evidence="42">
<original>T</original>
<variation>M</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_004253" evidence="38">
<original>G</original>
<variation>S</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_004254" evidence="34">
<original>G</original>
<variation>R</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; dbSNP:rs748427834." id="VAR_039023" evidence="16">
<original>V</original>
<variation>E</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="sequence variant" description="In a compound heterozygote carrying H-164; intermediate phenotype between LCATD and FED; reduction of activity." id="VAR_039024" evidence="18">
<original>G</original>
<variation>R</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; loss of activity." id="VAR_066862" evidence="25">
<original>W</original>
<variation>S</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_039025" evidence="16">
<original>S</original>
<variation>P</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; dbSNP:rs28940886." id="VAR_004255" evidence="35 36">
<original>A</original>
<variation>T</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; dbSNP:rs140068549." id="VAR_039026" evidence="41">
<original>R</original>
<variation>C</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with low HDL-cholesterol levels; results in reduced activity." id="VAR_066863" evidence="25">
<original>EY</original>
<variation>DN</variation>
<location>
<begin position="134"/>
<end position="135"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; dbSNP:rs121908050." id="VAR_004256" evidence="22">
<original>T</original>
<variation>I</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; dbSNP:rs768017317." id="VAR_039027" evidence="37">
<original>R</original>
<variation>Q</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; dbSNP:rs28940887." id="VAR_004257" evidence="36">
<original>R</original>
<variation>W</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_039028" evidence="16">
<original>R</original>
<variation>C</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; also in a compound heterozygote carrying R-95 with intermediate phenotype between LCATD and FED; loss of activity; dbSNP:rs769485083." id="VAR_004258" evidence="18 32">
<original>R</original>
<variation>H</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_039029" evidence="16">
<original>A</original>
<variation>T</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_004259" evidence="16 26">
<original>R</original>
<variation>W</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; dbSNP:rs749740660." id="VAR_004260">
<original>Y</original>
<variation>N</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs387906300." id="VAR_004261" evidence="35 36">
<original>R</original>
<variation>C</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_039030" evidence="16">
<original>S</original>
<variation>N</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986970." id="VAR_017030" evidence="11 12 21">
<original>S</original>
<variation>T</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; dbSNP:rs28942087." id="VAR_004262" evidence="36">
<original>L</original>
<variation>P</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_039031" evidence="16">
<original>K</original>
<variation>N</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with low HDL-cholesterol levels; the mutant is hardly secreted and is catalytically inactive." id="VAR_066864" evidence="25">
<original>V</original>
<variation>F</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; dbSNP:rs121908049." id="VAR_004263" evidence="20">
<original>N</original>
<variation>K</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with low HDL-cholesterol levels; the mutant is hardly secreted and is catalytically inactive; dbSNP:rs745320775." id="VAR_066865" evidence="25">
<original>R</original>
<variation>C</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; dbSNP:rs780824776." id="VAR_039032" evidence="16">
<original>R</original>
<variation>H</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; dbSNP:rs121908054." id="VAR_004264" evidence="14">
<original>M</original>
<variation>K</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In FED and LCATD." id="VAR_039033" evidence="10 16">
<original>T</original>
<variation>A</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_039034" evidence="16">
<original>T</original>
<variation>I</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; partially defective enzyme; dbSNP:rs121908048." id="VAR_004265" evidence="20 23">
<original>M</original>
<variation>I</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with low HDL-cholesterol levels; reduced protein secretion." id="VAR_066866" evidence="25">
<original>R</original>
<variation>C</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_039035" evidence="42">
<original>P</original>
<variation>S</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; dbSNP:rs776035233." id="VAR_039036" evidence="16 17">
<original>V</original>
<variation>M</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; results in reduced protein secretion and activity." id="VAR_066867" evidence="25">
<original>L</original>
<variation>F</variation>
<location>
<position position="338"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD; dbSNP:rs28940888." id="VAR_004266" evidence="11 36">
<original>T</original>
<variation>M</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; results in reduced activity; dbSNP:rs202017590." id="VAR_066868" evidence="25">
<original>R</original>
<variation>C</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In FED; dbSNP:rs121908053." id="VAR_004267" evidence="22">
<original>T</original>
<variation>M</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with LCATD." id="VAR_039037" evidence="16 21">
<original>L</original>
<variation>R</variation>
<location>
<position position="396"/>
</location>
</feature>
<feature type="sequence variant" description="In LCATD." id="VAR_039038" evidence="11">
<original>F</original>
<variation>V</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased activity towards PAPC. Increased PAPC/POPC activity ratio." evidence="13">
<original>E</original>
<variation>A</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little change in enzyme specific activity nor in PAPC/POPC activity ratio." evidence="13">
<original>E</original>
<variation>D</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased enzyme specific activity. Increased PAPC/POPC activity ratio." evidence="13">
<original>E</original>
<variation>K</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased activity towards PAPC. Increased PAPC/POPC activity ratio." evidence="13">
<original>E</original>
<variation>L</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased enzyme specific activity. Increased PAPC/POPC activity ratio." evidence="13">
<original>E</original>
<variation>Q</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; CAB56610/AAA59499." ref="8" evidence="43">
<original>I</original>
<variation>H</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="49"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="60"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="82"/>
<end position="86"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="95"/>
<end position="103"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="105"/>
<end position="107"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="114"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="121"/>
<end position="123"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="125"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="131"/>
<end position="134"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="142"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="146"/>
<end position="153"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="160"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="178"/>
<end position="195"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="199"/>
<end position="204"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="206"/>
<end position="217"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="220"/>
<end position="226"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="227"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="242"/>
<end position="248"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="250"/>
<end position="252"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="255"/>
<end position="257"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="258"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="270"/>
<end position="272"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="274"/>
<end position="276"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="280"/>
<end position="282"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="288"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="299"/>
<end position="301"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="302"/>
<end position="308"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="312"/>
<end position="321"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="322"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="335"/>
<end position="350"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="353"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="361"/>
<end position="373"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="374"/>
<end position="377"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="378"/>
<end position="383"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="386"/>
<end position="389"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="391"/>
<end position="397"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="401"/>
<end position="403"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="404"/>
<end position="406"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="408"/>
<end position="419"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="420"/>
<end position="422"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4X96"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4XWG"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4XX1"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5BV7"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5TXF"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10037"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10222237"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10329423"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10722751"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11423760"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12957688"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12966036"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14636062"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1516702"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1571050"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15994445"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16051254"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16216249"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1681161"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16874701"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1737840"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1859405"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19065001"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21901787"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2370048"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25727495"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26195816"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2880847"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3458198"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3797244"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7607641"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7613477"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7711728"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8318557"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8432868"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8620346"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8807342"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8820107"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9007616"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9261271"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9741700"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000305"/>
<evidence key="44" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14636062"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26195816"/>
</source>
</evidence>
<sequence length="440" mass="49578" checksum="B315EF118AA7A378" modified="1987-03-20" version="1" precursor="true">
MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQL
EAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGV
QIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEY
YRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGS
IKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGR
DFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDP
VGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLG
AYRQGPPASPTASPEPPPPE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>